American Journal of Obstetrics & Gynecology
Volume 187, Issue 5 , Pages 1389-1394 , November 2002

Evening primrose oil and fish oil for severe chronic astalgia: A randomized, double-blind, controlled trial

Received 17 January 2002 ,Revised 20 May 2002 ,Accepted 6 June 2002.

References 

  1. Roberts MM. Consultations for breast disease in general practice and hospital referral patterns. Br J Surg. 1984;74:1020–1022
  2. Nichols S, Waters WE, Wheeler MJ. Management of female breast disease by Southampton general practitioners. BMJ. 1980;281:1450–1453
  3. In:  Hughes LE,  Mansel RE,  Webster DJT editor. Breast pain and nodularity. London: Baillière Tindall; 1989;p. 75–92 Benign disorders of and diseases of the breast: concepts and clinical management
  4. Pye JK, Mansel RE, Hughes LE. Clinical experience of drug treatments for mastalgia. Lancet. 1985;2:373–377
  5. Mansel RE, Wisbey JR, Hughes LE. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Br J Surg. 1978;65:724–727
  6. Blichert-Toft M, Watt-Boolsen S. Clinical approach to women with severe mastalgia and the therapeutic possibilities. Acta Obstet Gynecol Scand Suppl. 1984;123:185–188
  7. Gateley CA, Miers M, Mansel RE, Hughes LE. Drug treatments for mastalgia: 17 years experience in the Cardiff mastalgia clinic. J R Soc Med. 1992;85:12–15
  8. Gateley CA, Mansel RE. Management of cyclical breast pain. Br J Hosp Med. 1990;43:330–332
  9. Schmidt Steinbrunn B, Zera RT, Rodriguez JL. Mastalgia: tailoring treatment to type of breast pain. Postgrad Med. 1997;102:183–198
  10. Pashby NL, Mansel RE, Hughes LE, Hanslip JI, Preece PE. A clinical trial of evening primrose oil in mastalgia. Br J Surg. 1981;68:801
  11. Horrobin DF, Manku MS. Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism. Prostaglandins Leukot Essent Fatty Acids. 1989;37:255–261
  12. Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal fatty acid levels in plasma of women with premenstrual syndrome. Am J Obstet Gynecol. 1984;150:363–366
  13. Willis AL. Nutritional and pharmacological factors in eicosanoid biology. Nutr Rev. 1981;39:289–301
  14. Buck AC, Davies RL, Harrison T. The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis. J Urol. 1991;146:188–194
  15. Goodnight SHJ, Harris WS, Connor WE, Illingworth DR. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis. 1982;2:87–113
  16. Mansel RE. Breast pain. BMJ. 1994;309:866–868
  17. Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol. 1992;5:837–841
  18. Dunn OJ, Clark VA. Applied statistics: analysis of variance and regression. In: New York: Wiley; 1974;p. 139–140
  19. Grimm H. Analysis of variance. In:  Bouet D, et al. editor. Biostatistics in pharmacology II. Oxford (UK): Pergamon Press; 1973;p. 705
  20. CPMP Working Party on the Efficacy of Medicinal Products . Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products: note for guidance III/3630/92-EN. Stat Med. 1995;14:1672–1674
  21. Wetzig NR. Mastalgia: a 3-year Australian study. Aust N Z J Surg. 1994;64:329–331
  22. Preece PE, Hanslip JI, Gilbert L. Evening primrose oil (Efamol) for mastalgia. In:  Horrobin DF editors. Clinical uses of essential fatty acid. Montreal: Eden; 1982;p. 147–154
  23. Mansel RE, Pye JK, Hughes LE. A controlled trial of evening primrose oil (Efamol) in cyclic premenstrual mastalgia. In: Proceedings of the 2nd International Symposium on Premenstrual, Postpartum, and Menopausal Mood Disorders; 1987; Kiawah Island, SC. Kiawah Island: The Symposium; 1987; [abstract 47]
  24. Meyer EC, Sommers DK, Reitz CJ, Mentis H. Vitamin E and benign breast disease. Surgery. 1990;107:549–551
  25. Ernster VL, Goodson WH, Hunt TK, Petrakis NL, Sickles EA, Miike R. Vitamin E and benign breast “disease ”: a double-blind, randomized clinical trial. Surgery. 1985;97:490–494

☆ Supported by ZorgOnderzoek Nederland (CareResearch Netherland, formerly: Praeventiefonds), Postbus 93245, 2509 AE The Hague, grant No. 28-2363.

☆☆ Reprint requests: E. S. M. de Lange-de Klerk, Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. E-mail: ESM.de_Lange.biostat@med.vu.nl

PII: S0002-9378(02)00425-8

doi: 10.1067/mob.2002.127377a

American Journal of Obstetrics & Gynecology
Volume 187, Issue 5 , Pages 1389-1394 , November 2002

Article Tools